The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC. (2023)

First Author: Javitt A
Attributed to:  Enhancing immunogenicity in non-viral low mutation burden tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s43018-023-00557-4

PubMed Identifier: 37217651

Publication URI: http://europepmc.org/abstract/MED/37217651

Type: Journal Article/Review

Volume: 4

Parent Publication: Nature cancer

Issue: 5

ISSN: 2662-1347